|
End-of-day quote
Dhaka S.E.
05/10/2026
|
5-day change | 1st Jan Change | ||
| 61.10 BDT | -1.61% |
|
-2.71% | +17.73% |
| Market Cap | 7.74B 63.05M 56.02M 52.29M 47.66M 89.88M 6.06B 90.72M 633M 245M 3.1B 237M 232M 9.94B | P/E 2024 |
23.2x | P/E 2025 | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 12.17B 99.12M 88.07M 82.2M 74.92M 141M 9.53B 143M 995M 385M 4.87B 372M 364M 15.63B | EV / Sales 2024 |
2.09x | EV / Sales 2025 | 1.11x |
| Free-Float |
68.17% | Yield 2024 |
1.6% | Yield 2025 | 2.78% |
| 1 day | -1.61% | ||
| 1 week | -2.71% | ||
| Current month | -4.68% | ||
| 1 month | -9.62% | ||
| 3 months | -14.66% | ||
| 6 months | +5.89% | ||
| Current year | +17.73% |
| 1 week | 61 |  | 65.3 |
| 1 month | 60 | | 68.1 |
| Current year | 50.7 | | 78 |
| 1 year | 45.5 | | 78 |
| 3 years | 36.2 | | 118.9 |
| 5 years | 26.4 | | 132 |
| 10 years | 26.4 | | 132 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mohammad Shafiq
CEO | Chief Executive Officer | 65 | 25/11/2020 |
Hassan Sarwar
DFI | Director of Finance/CFO | - | 01/07/2024 |
Shamim Rabbani
COO | Chief Operating Officer | 66 | 01/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Mohammad Shafiq
BRD | Director/Board Member | 65 | 25/11/2020 |
Javed Ally
BRD | Director/Board Member | 56 | 25/11/2020 |
Sayeed Ahmed
BRD | Director/Board Member | 48 | 25/11/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | -2.71% | +6.45% | -31.12% | 54.31M | |
| +0.58% | -3.26% | +35.63% | +111.67% | 1,019B | |
| -0.96% | -6.97% | +34.45% | +61.00% | 617B | |
| -0.05% | -1.70% | +13.71% | +77.52% | 464B | |
| -3.25% | -6.46% | +56.63% | +34.25% | 356B | |
| +0.93% | -2.22% | +20.49% | +40.86% | 333B | |
| +0.12% | -4.30% | +9.81% | +33.19% | 267B | |
| -1.11% | -6.15% | -7.87% | +7.54% | 244B | |
| -0.83% | -4.72% | +35.45% | +50.29% | 218B | |
| -0.65% | -5.85% | +26.17% | +91.83% | 179B | |
| Average | -0.69% | -3.46% | +23.09% | +47.70% | 369.72B | |
| Weighted average by Cap. | -0.32% | -3.54% | +28.14% | +67.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.9B 56.16M 49.9M 46.57M 42.45M 80.06M 5.4B 80.8M 564M 218M 2.76B 211M 206M 8.86B | 8.84B 71.99M 63.97M 59.7M 54.42M 103M 6.92B 104M 722M 280M 3.54B 270M 264M 11.35B |
| Net income | 405M 3.29M 2.93M 2.73M 2.49M 4.7M 317M 4.74M 33.06M 12.81M 162M 12.37M 12.1M 520M | 488M 3.97M 3.53M 3.29M 3M 5.66M 382M 5.71M 39.86M 15.44M 195M 14.91M 14.59M 626M |
| Net Debt | 5.03B 40.97M 36.4M 33.97M 30.97M 58.4M 3.94B 58.95M 411M 159M 2.01B 154M 150M 6.46B | 4.43B 36.07M 32.04M 29.91M 27.26M 51.41M 3.47B 51.89M 362M 140M 1.77B 135M 132M 5.69B |
Employees
4,798
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | BDT 61.10 | -1.61% | 261,077 |
| 04/10/26 | BDT 62.10 | -2.20% | 196,966 |
| 01/10/26 | BDT 63.50 | -0.94% | 220,458 |
| 30/09/26 | BDT 64.10 | +2.07% | 439,882 |
| 29/09/26 | BDT 62.80 | -0.48% | 203,400 |
- Stock Market
- Stocks
- NAVANAPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
